Rapid Market Expansion Helix Diagnostics has recently engaged in high-profile collaborations, such as partnering with Ginkgo Bioworks for COVID-19 pooled testing in school districts, indicating a growing footprint in scalable, large-volume testing projects within the biotech and educational sectors.

Focused on RNA Therapeutics Specializing in assays that support the development and safety validation of oligonucleotide drugs, Helix operates in the fast-growing RNA therapy sector, presenting opportunities to supply advanced testing solutions to emerging biotech firms focused on gene therapy innovations.

Cost-Effective Testing Solutions Helix offers proprietary, integrated high-throughput assays that streamline safety and identity testing, making it an attractive partner for companies seeking to reduce assay costs and accelerate regulatory approvals within the biotech and pharmaceutical industries.

Niche Industry Expertise As a specialized Contract Research Organization with a unique assay technology, Helix is positioned to serve clients aiming to differentiate through innovative testing methods, presenting a sales opportunity in expanding its client base among biotech startups and research institutions.

Growing Digital Footprint Although a small operation with limited staff, Helix maintains an active online presence and recent news coverage, suggesting an openness to digital marketing and outreach initiatives that can help target additional biotech firms, educational institutions, and government agencies seeking advanced diagnostics.